Literature DB >> 19230536

The long-term risks of infection and amputation with limb salvage surgery using endoprostheses.

Lee Jeys1, Robert Grimer.   

Abstract

Endoprostheses are now an established technique to reconstruct defects following bone tumour resection. The long-term durability of the reconstruction is excellent, with limb salvage being maintained in the long-term in 91% of patients at 20 years from surgery. The main reasons for secondary amputation were locally recurrent disease and deep periprosthetic infection. Infection remains one of the biggest threats to early failure of reconstructions with endoprostheses. Most series of reconstructions show a periprosthetic infection rate of approximately 10%. Infection most frequently occurs within 12 months from the last surgical procedure; however, the risk of infection is life-long. The commonest pathogenic organism is coagulase-negative Staphylococcus. The most effective treatment for deep infection is two-stage revision, with local treatments having little chance of curing deep infection. Research is on-going into surface treatments with silver and other materials to help to reduce the infection rates.

Entities:  

Mesh:

Year:  2009        PMID: 19230536     DOI: 10.1007/978-3-540-77960-5_7

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  29 in total

1.  What is the Likelihood That Tumor Endoprostheses Will Experience a Second Complication After First Revision in Patients With Primary Malignant Bone Tumors And What Are Potential Risk Factors?

Authors:  C Theil; J Röder; G Gosheger; N Deventer; R Dieckmann; D Schorn; J Hardes; D Andreou
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

Review 2.  Imaging following surgery for primary appendicular bone tumours.

Authors:  Imran Khan; Craig Gerrand; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-22       Impact factor: 2.199

3.  Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner.

Authors:  Karthik Sambanthamoorthy; Ankush A Gokhale; Weiwei Lao; Vijay Parashar; Matthew B Neiditch; Martin F Semmelhack; Ilsoon Lee; Christopher M Waters
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

4.  What are the Oncologic and Functional Outcomes After Joint Salvage Resections for Juxtaarticular Osteosarcoma About the Knee?

Authors:  Jing Li; Zhen Wang; Chuanlei Ji; Guojing Chen; Dong Liu; Haodong Zhu
Journal:  Clin Orthop Relat Res       Date:  2017-04-19       Impact factor: 4.176

5.  Late complications and survival of endoprosthetic reconstruction after resection of bone tumors.

Authors:  Ahmad Shehadeh; Jenna Noveau; Martin Malawer; Robert Henshaw
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

6.  Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development.

Authors:  Karthik Sambanthamoorthy; Chunyuan Luo; Nagarajan Pattabiraman; Xiarong Feng; Benjamin Koestler; Christopher M Waters; Thomas J Palys
Journal:  Biofouling       Date:  2013-10-11       Impact factor: 3.209

Review 7.  [Risk factors and management strategies for early and late infections following reconstruction with special tumour endoprostheses].

Authors:  V Janz; J Löchel; A Trampuz; K-D Schaser; A Hofer; G I Wassilew
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

Review 8.  [Replacement of infected knee and hip endoprostheses].

Authors:  M Militz; V Bühren
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

Review 9.  Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: a systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery.

Authors:  Michele Fiore; Andrea Sambri; Riccardo Zucchini; Claudio Giannini; Davide Maria Donati; Massimiliano De Paolis
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-09-05

Review 10.  [Osteosarcoma and chondrosarcoma of the pelvis and lower extremities].

Authors:  W K Guder; J Hardes; G Gosheger; M Nottrott; A Streitbürger
Journal:  Chirurg       Date:  2015-10       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.